Ownership history in Caprock Group, LLC · 10 quarters on record
This page tracks every 13F SEC filing in which Caprock Group, LLC reported a position in APYX MEDICAL CORPORATION (APYX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 19,878 | -122 | -0.6% | 0.00% | $40K | $2.14 |
| 2025 Q1 | UNCHANGED | 20,000 | — | 0% | 0.00% | $27K | $1.37 |
| 2024 Q4 | UNCHANGED | 20,000 | — | 0% | 0.00% | $32K | $1.58 |
| 2024 Q3 | UNCHANGED | 20,000 | — | 0% | 0.00% | $25K | $1.24 |
| 2024 Q2 | REDUCED | 20,000 | -600 | -2.9% | 0.00% | $27K | $1.34 |
| 2024 Q1 | UNCHANGED | 20,600 | — | 0% | 0.00% | $28K | $1.36 |
| 2023 Q4 | REDUCED | 20,600 | -35 | -0.2% | 0.00% | $54K | $2.62 |
| 2023 Q3 | ADDED | 20,635 | +35 | +0.2% | 0.00% | $66K | $3.20 |
| 2023 Q2 | REDUCED | 20,600 | -40,000 | -66.0% | 0.01% | $104K | $5.03 |
| 2023 Q1 | INITIATED | 60,600 | — | — | 0.01% | $175K | $2.88 |
As of 2025 Q4 — sorted by position size